Monument Therapeutics
PrivateLast Round
VC Round
Feb 25, 2025
Est. Valuation
$10.91M
Total Funding Raised
$4.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Monument Therapeutics operates in Healthcare & Life Sciences and is based in Macclesfield. Its latest recorded funding round was a VC Round in February 2025.
Monument Therapeutics is a biotechnology company that develops novel drugs for serious diseases of the central nervous system by using proprietary digital biomarkers to identify patients with homogenous underlying neurobiology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monument Therapeutics Comparables
Compare Monument Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cumulus Neuroscience | 88% | |
| HMNC Brain Health | 80% | |
| Kynexis Therapeutics | 80% |
For institutional investors. Book with your work email.
Monument Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 25, 2025 | ||||
| VC Round | Oct 15, 2024 | ||||
| VC Round | Apr 18, 2024 | ||||
| Seed | Dec 14, 2021 | ||||
| Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Monument Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | VC Round |
| Cambridge Angels | VC Round |
| o2h ventures | Seed, VC Round |
| Innovate UK | VC Round |
| Catapult Ventures | Seed |
| Neo Kuma Ventures | Seed |
| Wren Capital | Seed, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 92% MoM, reaching 3.2K.
- Jun 18, 2026
Monthly visitors grew 56% MoM, from 2.6K to 4K.
For institutional investors. Book with your work email.
Monument Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Monument Therapeutics's valuation, stock price, and market status.
Is Monument Therapeutics a public or private company?
Monument Therapeutics is a private company.
What is the current stock price of Monument Therapeutics?
Monument Therapeutics is a private company, so its shares have no public market price. Caplight tracks Monument Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Monument Therapeutics worth (valuation)?
Monument Therapeutics's valuation is estimated at $10.9M based on funding round data.
Can I buy Monument Therapeutics stock?
Monument Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Monument Therapeutics's last funding round?
Monument Therapeutics's most recent funding round was VC Round on February 25, 2025.
Who are the main investors in Monument Therapeutics?
Key investors in Monument Therapeutics include ACF Investors, Cambridge Angels, Catapult Ventures, Neo Kuma Ventures, Catapult Ventures.
Will Monument Therapeutics IPO soon?
No public IPO plans have been announced for Monument Therapeutics.
How can I track Monument Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Monument Therapeutics's shares on secondary markets.